Developing new methods for creating complex organic compounds using light
New Synthetic Methods Enabled by Excited-State Redox Chemistry
This study is exploring new ways to use light to help create better medicines, which could lead to more effective treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Princeton University NIH-funded |
| Lab location | 1 site (Princeton, UNITED STATES) |
| Project ID | NIH-11011618 on NIH RePORTER |
What this research studies
This research focuses on creating innovative synthetic methods that tackle long-standing challenges in organic chemistry and catalysis. By utilizing excited-state redox chemistry, the project aims to harness light to drive chemical reactions in ways that traditional methods cannot achieve. Patients may benefit from the development of new drugs and therapeutic agents that arise from these advanced synthetic techniques, which could lead to more effective treatments. The research includes applications such as the transformation of amino alcohols into valuable cyclic compounds, which could have implications for drug development.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by novel drugs developed from these synthetic methods.
Not a fit: Patients with conditions that are not addressed by the types of compounds being synthesized may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new and more effective drugs and therapies for various health conditions.
How similar studies have performed: While the approach of using excited-state redox chemistry is innovative, similar methodologies in organic synthesis have shown promise, indicating potential for success.
Where this research is happening
Princeton, UNITED STATES
- Princeton University — Princeton, United States (Active)
Researchers
- Principal investigator: Knowles, Robert R — Princeton University
- Study coordinator: Knowles, Robert R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.